WF
Wellment Financial
13F filer · CIK 0001940000Reported Jul 23, 2026
13F portfolio value$87.8MU.S. long equity reported on 13F
Positions14Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight27.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 23, 202614 positions | |||||
| OBONEZOne Bio, Corp. | $9.23M | 10.51% | Not reported | +141.2% | Q1 2025 |
| $7.15M | 8.15% | Not reported | Not reported | Q4 2024 | |
| $1.65M | 1.88% | Not reported | -0.6% | Q4 2024 | |
| $1.45M | 1.65% | 0.00% | +4.1% | Q1 2026 | |
| $1.17M | 1.33% | 0.00% | +25.5% | Q4 2024 | |
| $1.09M | 1.24% | 0.00% | +29.9% | Q4 2024 | |
| $854K | 0.97% | Not reported | +0.8% | Q1 2026 | |
| $564K | 0.64% | 0.00% | -1.8% | Q1 2026 | |
| $473K | 0.54% | 0.00% | -0.2% | Q4 2024 | |
| $450K | 0.51% | 0.00% | +19.0% | Q3 2025 | |
| $319K | 0.36% | 0.00% | New | Q2 2026 | |
| $246K | 0.28% | 0.00% | Not reported | Q4 2024 | |
| $237K | 0.27% | Not reported | Not reported | Q4 2025 | |
| $215K | 0.25% | 0.00% | -31.7% | Q4 2025 | |
| Q1 2026Reported Apr 28, 202610 positions | |||||
| OBONEZOne Bio, Corp. | $3.47M | 4.29% | Not reported | +4.2% | Q1 2025 |
| $1.69M | 2.09% | Not reported | -0.6% | Q4 2024 | |
| $1.2M | 1.49% | 0.00% | New | Q1 2026 | |
| $812K | 1.00% | 0.00% | -0.8% | Q4 2024 | |
| $740K | 0.92% | Not reported | New | Q1 2026 | |
| $736K | 0.91% | 0.00% | -6.4% | Q4 2024 | |
| $650K | 0.80% | 0.00% | New | Q1 2026 | |
| $554K | 0.69% | 0.00% | -16.5% | Q4 2024 | |
| $334K | 0.41% | 0.00% | -1.5% | Q3 2025 | |
| $208K | 0.26% | 0.00% | -1.8% | Q4 2025 | |
| Q4 2025Reported Jan 27, 20269 positions | |||||
| OBONEZOne Bio, Corp. | $3.46M | 4.06% | Not reported | +0.9% | Q1 2025 |
| $1.96M | 2.30% | Not reported | +0.2% | Q4 2024 | |
| $1.57M | 1.84% | Not reported | New | Q4 2025 | |
| $876K | 1.03% | 0.00% | -4.7% | Q4 2024 | |
| $842K | 0.99% | 0.00% | -12.4% | Q4 2024 | |
| $611K | 0.72% | 0.00% | -1.0% | Q4 2024 | |
| $411K | 0.48% | 0.00% | +61.9% | Q3 2025 | |
| $260K | 0.31% | 0.00% | +13.0% | Q4 2024 | |
| $211K | 0.25% | 0.00% | New | Q4 2025 | |
| Q3 2025Reported Oct 29, 20258 positions | |||||
| OBONEZOne Bio, Corp. | $3.5M | 4.14% | Not reported | +51.2% | Q1 2025 |
| $2.18M | 2.58% | Not reported | -0.3% | Q4 2024 | |
| $1.19M | 1.41% | Not reported | -1.3% | Q1 2025 | |
| $919K | 1.09% | 0.00% | -10.9% | Q4 2024 | |
| $901K | 1.07% | 0.00% | +14.8% | Q4 2024 | |
| $554K | 0.66% | 0.00% | -0.2% | Q4 2024 | |
| $251K | 0.30% | 0.00% | New | Q3 2025 | |
| $246K | 0.29% | 0.00% | +13.3% | Q4 2024 | |
Premium opens every quarter this fund has filed